RAMM — Ramm Pharma Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapValue Trap

Annual balance sheet for Ramm Pharma, fiscal year end - October 31st, CAD millions except per share, conversion factor applied.

	R2021 October 31st	R2022 October 31st	2023 October 31st	2024 October 31st	2025 October 31st
Period Length:	—	—	—	—	—
Source:	Interim Report	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	17.2	9.77	5.12	0.814	0.804
Net Total Accounts Receivable
Net Total Receivables	3.95	2.74	1.88	1.64	0.877
Total Inventory
Prepaid Expenses
Total Current Assets	24.3	16.7	10.6	5.36	2.64
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	19.3	19.7	19	11.2	6.63
Net Goodwill
Net Intangible Assets
Long Term Notes Receivable
Total Assets	59.8	39.2	32.3	16.7	9.27
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	3.32	3.2	2.66	3.03	3.56
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Liabilities	3.46	3.66	2.84	3.11	3.57
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	56.4	35.6	29.5	13.6	5.7
Total Liabilities & Shareholders' Equity	59.8	39.2	32.3	16.7	9.27
Total Common Shares Outstanding